Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review

Overview of attention for article published in PLOS ONE, March 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 71 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 56 publications that cite this research output.

56

The most recent citing publications are shown below. View all 56 publications that cite this research output on Dimensions.

The Potential of CD4+ T cells ATP level to indicate the Progression in NSCLC Patients

Preprint in Research Square (December 2023)

Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma

Article in Frontiers in Cell and Developmental Biology (September 2023)

A prognostic model for predicting progression-free survival in patients with advanced non-small cell lung cancer after image-guided microwave ablation plus chemotherapy

Article in European Radiology (June 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.